How to treat elderly CLL patients in the light of novel therapies
Recent developments in the mutational landscape and molecular basis of AML
The importance of venetoclax in treating CLL
Making an IMPACT in ALL therapy: how can cure rates be improved?
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?